Vernal Keratoconjunctivitis Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Vernal Keratoconjunctivitis Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
Request Sample Of This Report @ https://www.coherentmarketinsights.com/insight/request-sample/4657
Major Players In This Market Are: Santen, Novartis Pharmaceuticals, Senju Pharmaceutical, Allakos, iCo Therapeutics, and Akari Therapeutics.
Market Overview:
Vernal keratoconjunctivitis is an allergic eye disease that especially affects young boys. It is caused by a hypersensitivity to airborne-allergens. The condition generally resolves spontaneously after puberty without any further symptoms or visual complications. Treatment may include, antihistamine or anti-inflammatory drops that are placed into the eye.
Key Market Drivers:
High prevalence of vernal keratoconjunctivitis is expected to propel growth of the global vernal keratoconjunctivitis market over the forecast period. For instance, according to the study, ‘Prevalence of vernal keratoconjunctivitis and its associated factors among children in Gambella town, southwest Ethiopia, June 2018’, published in PLoS One, the prevalence of vernal keratoconjunctivitis was 11.10%.
Moreover, approval and launch of new products is also expected to propel growth of the global vernal keratoconjunctivitis market over the forecast period. For instance, in June 2021, Santen Pharmaceutical Co. received the U.S. Food and Drug Administration approval for Verkazia for the treatment of vernal keratoconjunctivitis in children and adults.
Covid-19 Impact Analysis
Globally, as of 7:34pm CET, 6 December 2021, there have been 265,194,191 confirmed cases of COVID-19, including 5,254,116 deaths, reported to WHO. As of 6 December 2021, a total of 7,952,750,402 vaccine doses have been administered. The occurrence of conjunctivitis has been reported in COVID-19 patients manifesting as conjunctival redness, irritation, foreign body sensation. It has also been reported that antiviral response in vernal keratoconjunctivitis may be protective against COVID-19.
Key Takeaways
Major players operating in the global vernal keratoconjunctivitis market are focused on R&D to expand their product portfolio. For instance, in October 2021, Akari Therapeutics, Plc announced data highlighting the potential of nomacopan in the surface of the eye in Allergy, European Journal of Allergy and Clinical Immunology.
Buy this research report here: https://www.coherentmarketinsights.com/insight/buy-now/4657
Table of Contents
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Drug Type
- Market Snapshot, By Treatment
- Market Snapshot, By Dosage Form
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunity
- Impact Analysis
- Pipeline Analysis
- Regulatory Scenario
- Market Trends
- Key Developments
- Epidemiology
- PEST Analysis
- Brand Analysis
- Market Dynamics
- Global Vernal Keratoconjunctivitis Market– Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Epidemiology
- Supply and Demand Analysis
- Key Developments
- Global Vernal Keratoconjunctivitis Market, By Drug Type, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Bertilimumab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Verkazia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Lodoxamide
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Tacrolimus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antolimab
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Nomacopan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Vernal Keratoconjunctivitis Market, By Treatment, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Mast Cell Stabilizers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Antihistamines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Topical Corticosteroids
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Cyclosporine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Tacrolimus
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Vernal Keratoconjunctivitis Market, By Dosage Form, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Gel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Ointment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Tablet
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Mn)
- Introduction
- Global Vernal Keratoconjunctivitis Market, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 – 2028
- Segment Trends
- Hospital Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Retail Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Online Pharmacy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 – 2028, (US$ Million)
- Introduction
- Global Vernal Keratoconjunctivitis Market, By Region, 2017 – 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2021 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2028
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type , 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- U.K.
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries, 2017 – 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Drug Type, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Dosage Form, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 – 2028, (US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Countries/Region, 2017 – 2028, (US$ Mn)
- North Africa
- Central Africa
- South Africa
- Introduction
In this study, the years considered to estimate the market size of Vernal Keratoconjunctivitis are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Vernal Keratoconjunctivitis Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Vernal Keratoconjunctivitis Market are also given.
Press Release: https://www.coherentmarketinsights.com/press-release/vernal-keratoconjunctivitis-market-3914
About Coherent Market Insights
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837